AGTR1 and kidney disorder: The fact that the blockade of the AT1R with ARBs abolishes all these untoward actions of Ang II can explain the protective effects of these agents in patients at high risk for several cardiovascular and renal disease conditions who are being treated with these drugs because of an activated RAS.